- Home
- GRRR vs AMLX Comparison
GRRR vs AMLX Comparison
Compare GRRR & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRRR
- AMLX
- Stock Information
- Founded
- GRRR 2001
- AMLX 2014
- Country
- GRRR United Kingdom
- AMLX United States
- Employees
- GRRR N/A
- AMLX N/A
- Industry
- GRRR Computer Software: Prepackaged Software
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- GRRR Technology
- AMLX Health Care
- Exchange
- GRRR Nasdaq
- AMLX Nasdaq
- Market Cap
- GRRR 387.9M
- AMLX 459.1M
- IPO Year
- GRRR N/A
- AMLX 2022
- Fundamental
- Price
- GRRR $25.90
- AMLX $5.05
- Analyst Decision
- GRRR Buy
- AMLX Buy
- Analyst Count
- GRRR 1
- AMLX 6
- Target Price
- GRRR $18.00
- AMLX $10.17
- AVG Volume (30 Days)
- GRRR 2.0M
- AMLX 911.0K
- Earning Date
- GRRR 06-18-2025
- AMLX 08-07-2025
- Dividend Yield
- GRRR N/A
- AMLX N/A
- EPS Growth
- GRRR N/A
- AMLX N/A
- EPS
- GRRR N/A
- AMLX N/A
- Revenue
- GRRR $84,196,961.00
- AMLX N/A
- Revenue This Year
- GRRR $36.59
- AMLX N/A
- Revenue Next Year
- GRRR $30.68
- AMLX N/A
- P/E Ratio
- GRRR N/A
- AMLX N/A
- Revenue Growth
- GRRR 19.91
- AMLX N/A
- 52 Week Low
- GRRR $2.09
- AMLX $1.62
- 52 Week High
- GRRR $44.15
- AMLX $7.27
- Technical
- Relative Strength Index (RSI)
- GRRR 67.95
- AMLX 48.04
- Support Level
- GRRR $18.14
- AMLX $5.24
- Resistance Level
- GRRR $20.34
- AMLX $5.66
- Average True Range (ATR)
- GRRR 2.06
- AMLX 0.34
- MACD
- GRRR 0.35
- AMLX -0.05
- Stochastic Oscillator
- GRRR 91.61
- AMLX 21.97
About GRRR Gorilla Technology Group Inc.
Gorilla Technology Group Inc is engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.